Skip to content

Search from site

Type your search terms and select from the suggestions or click the search button to move to the search page.

    Tampere is home for a variety of world-class health and life science innovations. Over a century old pharma industry heritage, pioneering research in biodegradable polymers and regenerative medicine all the way to world-class diabetes and oncological research of today, have home in Tampere region.

    Tampere University and the Tampere University Hospital provide excellent research, preclinical and clinical services. Not to forget that Finland possess one of the world’s greatest health-data assets.

    Tampere University Hospital RDI centerHealthHUBBiobank and the BioMediTech institute along with testing and education providers help you find out more and explore this opportunity.

    For innovation activities Tampere offers also strong regulatory knowledge and for companies. There are both consultancy and electronic evaluation tools available.

    Pharma and medical biotechnology

    Tampere has very strong research capabilities for cardiovascular diseases, vaccines, celiac disease, oncology and pediatric diseases. Bioinformatics and clinical informatics provide new opportunities for health technology.

    Tampere University Hospital offers excellent conditions for clinical research, which is supported by the Finnish Clinical Biobank Tampere (FCBT). FCBT is the fastest growing biobank in Finland and it is developing new methods for instance using cold chain robotics in the sample handling.

    As an example, Santen, a world leading Ophthalmology company, has a major R&D unit in Tampere. In biotechnology, Tampere  is particularly strong in the fields of tissue engineering and stem cell therapy. The prime example being a bone graft cultured from stem cells isolated from patient’s own tissue and grown inside his abdomen.

    Health IT and digital health

    Tampere is the center of ICT developing new solutions also to health and well-being sector.

    Large companies are developing patient record systems to hospitals, as well as UNA Oy, which is a joint project of municipalities to create common database for hospital patient records. In addition, several smaller companies are developing IT solutions to hospitals and applications for end users.

    In the Tampere region, there’s a lot of R&D activity for peripheral devices and sensors of digital health applications. For instance, the first heart rate monitoring belt for consumers based on textile electronics was developed in Tampere, as well as a big part of wearables and sensors used for MyData collection today. Digitalisation supports personalized care pathways and virtual policlinic solutions.


    Back to top